Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LVIII.q

Path: Pneumocyte atypia (reactive epithelial cells) (a.k.a. the "Napoleon Hat" sign)

Publications

Topilow AA, Rothenberg SP, Cottrell TS

Interstitial pneumonia after prolonged treatment with cyclophosphamide.

The American review of respiratory disease 1973 Jul;108;114-7 — 1973 Jul — 114-7

Patel AR, Shah PC, Rhee HL, Sassoon H, Rao KP

Cyclophosphamide therapy and interstitial pulmonary fibrosis.

Cancer 1976 Oct;38;1542-9 — 1976 Oct — 1542-9